[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100440706":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":26,"centralContacts":21,"locations":30,"responsibleParty":66,"collaborators":21,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":21,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":21,"maxAge":21,"enrollmentInfo":76,"targetDuration":21,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":33,"whyStopped":21,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"The Foundation for Orthopaedics and Regenerative Medicine","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment Group","EXPERIMENTAL","Single intrathecal injection of 100 million cells",[13,14],"Biological: autologous adipose derived mesenchymal stem cells","Biological: AlloRx",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"BIOLOGICAL","autologous adipose derived mesenchymal stem cells","cultured autologous adult adipose derived mesenchymal stem cells",[9],null,{"type":17,"name":23,"description":24,"armGroupLabels":25,"otherNames":21},"AlloRx","Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal injection for",[9],[27],{"name":28,"affiliation":5,"role":29},"Chadwick Prodromos, MD","PRINCIPAL_INVESTIGATOR",[31,49],{"facility":32,"status":33,"city":34,"state":21,"zip":21,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Medical Surgical Associates Center","RECRUITING","St John's","Antigua and Barbuda","AG",{"type":38,"coordinates":39},"Point",[40,41],-61.84329,17.12096,{"lat":41,"lon":40},[44],{"name":45,"role":46,"phone":47,"phoneExt":21,"email":48},"Chadwick C Prodromos, MD","CONTACT","847-699-6810","care@thepsci.net",{"facility":50,"status":33,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Athens Beverly Hills Medical Group","Glyfada","Athens","16675","Greece","GR",{"type":38,"coordinates":57},[58,59],23.75802,37.86289,{"lat":59,"lon":58},[62,65],{"name":45,"role":46,"phone":63,"phoneExt":21,"email":64},"8476996810","care@thepsci.com",{"name":28,"role":46,"phone":21,"phoneExt":21,"email":21},{"type":67,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR","100440706","phase-1-safety-of-cultured-autologous-adult-adipose-derived-mesenchymal-stem-cell-versus-cultured-allogeneic-adult-umbilical-cord-derived-mesenchymal-stem-cell-intrathecal-injection-for-sci-100440706",false,"NCT05018793","Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI","Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Spinal Cord Injury","Inclusion Criteria:\n\n* Diagnosis of Spinal Cord Injury\n* Understanding and willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Active infection\n* Active cancer\n* Chronic multisystem organ failure\n* Pregnancy\n* Anticoagulation medicine use\n* Clinically significant Abnormalities on pre-treatment laboratory evaluation\n* Medical condition that would (based on the opinion of the investigator) compromise patient's safety.\n* Previous organ transplant\n* Hypersensitivity to sulfur\n* Continued drug abuse\n* Pre-menopausal women not using contraception","ALL",{"count":77,"type":78},15,"ESTIMATED","INTERVENTIONAL",[81],"PHASE1","This trial will study the safety and efficacy of intrathecal injection of cultured autologous adult adipose derived mesenchymal stem cells versus cultured allogeneic adult umbilical-cord derived mesenchymal stem cells for the treatment of spinal cord injury",[84],"Spinal Cord Injuries",[86,87,88],"spinal cord injury","SCI","stem cell treatment","2025-04-15",{"date":91,"type":92},"2025-04-17","ACTUAL",{"date":94,"type":92},"2024-12-01",{"date":96,"type":78},"2028-12",{"name":5,"class":6},2]